Diagnostic and therapeutic ERβ, HER2, BRCA biomakers in the histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification-Reference-Cited by-同舟云学术

Diagnostic and therapeutic ERβ, HER2, BRCA biomakers in the histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification

Published:2021-04 Issue: Volume:51 Page:151700
ISSN:1092-9134
Container-title:Annals of Diagnostic Pathology
language:en
Short-container-title:Annals of Diagnostic Pathology

Author:

Zhong Lin,Zhang Chunfang,Jia Wenting,Zhang Pengxin

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference34 articles.

1. Sex-specificity in lung cancer risk;Stapelfeld;Int J Cancer,2020

2. Smoking, sex, and non-small cell lung cancer: steroid hormone receptors in tumor tissue (S0424);Cheng;J Natl Cancer Inst,2018

3. Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer;Marquez-Garban;Steroids,2011

4. Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation;Raso;Clin Cancer Res,2009

5. Combined analysis of estrogen receptor b-1 and progesterone receptor expression identifies lung cancer patients with poor outcome;Stabile;Clin Cancer Res,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Response Biomarkers: Working Toward Personalized Radiotherapy for Lung Cancer;Journal of Thoracic Oncology;2024-08

2. Selection of potential targets for stratifying congenital pulmonary airway malformation patients with molecular imaging: is MUC1 the one?;European Respiratory Review;2023-12-20

3. Niraparib for the Treatment of Metastatic NSCLC in a Patient With BRCA2 Germinal Mutation: A Case Report;Clinical Lung Cancer;2023-10

4. Evaluation of fluorine-18-fluorodeoxyglucose PET/computed tomography and human epithelial growth factor receptor 2 expression in treatment-naive patients with lung adenocarcinoma;Nuclear Medicine Communications;2022-01-17